Frankfurt - Delayed Quote EUR
Soleno Therapeutics, Inc. (6XC.F)
57.90
-1.00
(-1.70%)
At close: April 22 at 3:29:02 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 7 |
| Avg. Estimate | -- | 2.78M | 36M | 228.83M |
| Low Estimate | -- | -- | 6.94M | 35M |
| High Estimate | -- | 10.19M | 73.5M | 376M |
| Year Ago Sales | -- | -- | -- | 36M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 535.64% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 6XC.F | -- | -- | -- | -- |
| S&P 500 | 7.01% | 4.85% | 8.55% | 14.15% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/15/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/31/2025 |
| Maintains | Stifel: Buy to Buy | 3/28/2025 |
| Maintains | Guggenheim: Buy to Buy | 3/28/2025 |
| Maintains | Laidlaw & Co.: Buy to Buy | 3/27/2025 |
| Maintains | Baird: Outperform to Outperform | 3/27/2025 |
Related Tickers
DUL.SG Alnylam Pharmaceuticals Inc
205.70
+0.93%
CXF.F Chimerix, Inc.
7.48
0.00%
L9S.DU Gyre Therapeutics Inc
7.35
-0.68%
YDO1.BE Madrigal Pharmaceuticals Inc
253.00
-6.54%
87S.BE Roivant Sciences Ltd
8.59
-2.28%
L9S.F Gyre Therapeutics, Inc.
7.25
+3.57%
87S.MU Roivant Sciences Ltd
8.80
-0.95%
D01.BE BELITE BIO INC. R
47.60
-4.03%
CXF.MU Chimerix Inc
7.48
0.00%
9LB.DU Legend Biotech Corp
29.40
+2.08%